Gannon, Hannah
Chappell, Elizabeth
Ford, Deborah
Gibb, Diana M
Chimwaza, Anesu
Manika, Ngoni
Wedderburn, Catherine J
Nenguke, Zivai Mupambireyi
Cowan, Frances M
Gibb, Tom
Phillips, Andrew
Mushavi, Angela
Fitzgerald, Felicity
Heys, Michelle
Chimhuya, Simbarashe
Bwakura-Dangarembizi, Mutsa
Funding for this research was provided by:
ViiV Healthcare
Medical Research Council (MR/V029126/1, MC_UU_00004/03)
Wellcome Trust (215742/Z/19/Z: PI: Heys)
Article History
Received: 8 March 2023
Accepted: 7 December 2023
First Online: 5 January 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki. The Neotree study received approval from Sally Mugabe Central Hospital Research Ethics Committee (Reference number HCHEC070618/58), University College London Ethics Committee (5019/004), Biomedical Research and Training Institute (AP148/18) and the Medical Research Council of Zimbabwe MRCZ/A/2570. This study formed part of a wider mixed methods ViiV funded project; <i>“Evaluation of the Impact of the COVID-19 Pandemic on Provision and Uptake of Services for the Prevention of Mother-to-child Transmission of HIV and Syphilis in Zimbabwe”</i> and received ethics approval from the Medical Research Council of Zimbabwe MRCZ/A/2682. The Neotree follows international and local precedent for collection of pseudonymised data for the purposes of epidemiological surveillance and service evaluation such as the neonatal UK/Australia/New Zealand Badgernet system, or the WHO-led District Health Information Software (DHIS). The need to obtain informed consent was waived by each of the ethical boards; the Medical Research Council of Zimbabwe, University College London Ethics Committee, Biomedical Research and Training Institute and Sally Mugabe Central Hospital’s Ethics committee, as we collected only pseudonymised data routinely documented for clinical care.
: Not applicable.
: The authors declare no competing interests.